| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.20B | 2.42B | 2.81B | 3.01B | 3.18B |
| Gross Profit | 276.20M | 516.50M | 592.10M | 581.40M | 508.60M |
| EBITDA | -22.50M | 269.50M | 54.90M | 238.00M | 508.70M |
| Net Income | -164.10M | 76.70M | -178.10M | 74.80M | 224.70M |
Balance Sheet | |||||
| Total Assets | 1.74B | 1.84B | 2.00B | 2.55B | 3.14B |
| Cash, Cash Equivalents and Short-Term Investments | 264.10M | 254.00M | 155.40M | 396.80M | 317.60M |
| Total Debt | 457.00M | 680.30M | 721.00M | 903.30M | 1.24B |
| Total Liabilities | 1.70B | 1.64B | 1.88B | 2.20B | 2.85B |
| Stockholders Equity | 47.40M | 199.90M | 113.00M | 330.20M | 274.50M |
Cash Flow | |||||
| Free Cash Flow | -4.80M | -75.30M | -101.90M | 24.00M | -237.20M |
| Operating Cash Flow | 4.70M | -25.20M | -40.30M | 71.90M | -179.10M |
| Investing Cash Flow | -43.70M | 201.20M | 9.70M | 344.10M | 422.40M |
| Financing Cash Flow | -28.50M | -51.50M | -76.30M | -340.70M | -259.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.97B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
76 Outperform | £2.27B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £12.57B | 31.67 | 6.51% | 1.68% | -1.58% | -34.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | £327.84M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
42 Neutral | £1.86B | 126.90 | ― | 0.36% | -2.24% | ― | |
41 Neutral | £332.08M | -2.81 | -142.88% | ― | -4.87% | ― |